Chemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experience

dc.contributor.authorEren, Orhan Onder
dc.contributor.authorArtac, Mehmet
dc.contributor.authorBoruban, Melih Cem
dc.contributor.authorYavas, Ozlem
dc.contributor.authorArslan, Ugur
dc.contributor.authorBasaranoglu, Metin
dc.date.accessioned2020-03-26T17:38:02Z
dc.date.available2020-03-26T17:38:02Z
dc.date.issued2009
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractHepatitis B reactivation due to chemotherapy is a cause of serious morbidity and mortality in some of the patients with cancer. In this study, we retrospectively assessed the prevalence of hepatitis B reactivation among the patients undergoing cytotoxic chemotherapy. We investigated efficacy of lamivudine prophylaxis against hepatitis B reactivation as well.en_US
dc.identifier.doi10.1007/s12032-008-9133-4en_US
dc.identifier.endpage392en_US
dc.identifier.issn1357-0560en_US
dc.identifier.issn1559-131Xen_US
dc.identifier.issue4en_US
dc.identifier.pmid19021003en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage386en_US
dc.identifier.urihttps://dx.doi.org/10.1007/s12032-008-9133-4
dc.identifier.urihttps://hdl.handle.net/20.500.12395/23349
dc.identifier.volume26en_US
dc.identifier.wosWOS:000272045400002en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherHUMANA PRESS INCen_US
dc.relation.ispartofMEDICAL ONCOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectHepatitis Ben_US
dc.subjectCytotoxic chemotherapyen_US
dc.subjectReactivationen_US
dc.subjectCanceren_US
dc.subjectLamivudineen_US
dc.titleChemotherapy-induced Hepatitis B virus reactivation in HbsAg positive cancer patients: a single center experienceen_US
dc.typeArticleen_US

Dosyalar